Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

NCT06714838 is registered in ClinicalTrials.gov with Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC) as lead sponsor.

NCT NCT06714838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06714838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Lead sponsor
Amsterdam University Medical Center (UMC), Location Academic Medical Center (AMC)
Phase
Phase 3
Overall status
Recruiting
Start date
October 16, 2024
Completion date
October 31, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cidp